Patents
Patents for C07J 21 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, having an oxygen-containing hetero ring spiro-condensed with the cyclopenta[a]hydrophenanthrene skeleton (1,576)
03/2012
03/20/2012CA2498634C A process for the preparation of drospirenone
02/2012
02/15/2012EP2417149A1 Methods for the preparation of drospirenone
02/15/2012EP2417148A1 Progesterone antagonists spiro condensed in position 17 with a difluoromethylene- substituted perhydrofurane group
01/2012
01/18/2012CN102321139A Synthetic method of spironolactone
12/2011
12/28/2011CN1869053B 一种从西洋参叶中提取分离人参皂苷混合物的方法 A method for the extraction and separation of the mixture of ginsenosides from ginseng leaves
12/22/2011WO2011157443A1 (11b,17a)-11-(4-(2-11c-acetyl)phenyl)-17,23-epoxy-19,24-dinorchola-4,9,20-trien-3-one
11/2011
11/02/2011CN101466723B Industrial process for the synthesis of 17a-acetoxy-11ss-[4-(n,n-dimethyl-amino)- phenyl]-19-norpregna-4,9-diene-3,20-dione and new intermediates of the process
10/2011
10/27/2011US20110263553 Steroid analogues for neuroprotection
10/12/2011EP2160398B1 INDUSTRIAL METHOD FOR THE SYNTHESIS OF 17-ACETOXY-11ß-[4-(DIMETHYLAMINO)-PHENYL]-21-METHOXY-19-NORPREGNA-4,9-DIEN-3,20-DIONE AND THE KEY INTERMEDIATES OF THE PROCESS
09/2011
09/28/2011EP2367808A2 PROGESTATIONAL 3-(6,6-ETHYLENE-17b-HYDROXY-3-OXO-17a-PREGNA-4-ENE-17a-YL) PROPIONIC ACID g-LACTONES
09/20/2011US8021839 Quantitative analysis; optical properties; kits
09/14/2011CN102180933A Preparation method of skunk bugbane monomer components
09/14/2011CN102180932A Method for preparing steroid saponin DT-13
09/14/2011CN102180931A Method for extracting ardipusilloside
08/2011
08/30/2011US8007938 Nonaqueous electrolyte solution and lithium secondary battery using same
08/23/2011US8003629 21-substituted progesterone derivatives as new antiprogestational agents
08/11/2011US20110195942 Method of making and using 7alpha, 11beta-dimethyl-17beta-hydroxyestr-4-en-3-one 17-undecanoate
08/04/2011DE102010006885A1 Preparing drospirenone, comprises reacting methyleneprasterone with (ethoxyethoxy)-butene nitrile using strong base, converting methyleneprasteron-spirolactone, enolizing methylen-spirolacton-andro st-en-one, oxidizing and adding methylene
08/04/2011DE102010006884A1 Preparing drospirenone, comprises reacting methyleneprasterone with 1-halopropan-3-acetal compounds, oxidatively converting methylene-hydroxy-(dialkoxypropyl)-prasterone, enolizing methylen-spirolacton-androsten-one, and oxidizing
08/04/2011DE102010006818A1 Producing drospirenone, useful as hormonal contraceptives, by oxidatively converting hydroxy-dimethylenandrostane-one to hydroxy-dimethylenandrostan-dione, eliminating hydroxy group, followed by reacting with 1-halopropan-3-oxy
07/2011
07/27/2011EP2348033A2 Process for obtaining 17alfa-acetoxy-11beta-(4-n,n-dimethylaminophenyl)-19-norpregna-4,9-diene-3,20-dione
07/14/2011DE102010004452A1 Preparing drospirenone comprises reacting methyleneprasterone with strong base and with lithium and bromopropyl-trimethylsilylether, removing trimethylsilyl-protecting group and oxidatively cyclizing methylene-hydroxy-(propanol)-prasterone
07/14/2011DE102010004450A1 Making drospirenone, useful as hormonal contraceptive, comprises reacting methylenedienedione with strong base and bromopropyl-trimethylsilylether, removing trimethylsilyl group and cyclizing methylene-hydroxy-(propanol)-androst-dien-one
06/2011
06/23/2011WO2011075701A2 Methods for the purification of deoxycholic acid
06/23/2011CA2782478A1 Methods for the purification of deoxycholic acid
06/15/2011CN101177446B Novel method for stereo-selective chemosynthesis of drospirenone
06/07/2011CA2628607C Androgen synthesis inhibitors
05/2011
05/17/2011CA2423358C Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers
05/04/2011CN102040650A Method for constructing sterides-6beta, 7beta-methylene structure by cascade reaction
05/04/2011CN102040649A Synthesis process for preparing steride 6-fluorine with NFOBS (N-Fluoro-Ortho-Benzenedisulfonimide) or NBSI fluorinating agent
05/04/2011CN102040645A Synthetic process for preparing 6alpha-fluoro steroids by using NFOBS or NBSI fluorinating agent
03/2011
03/23/2011CN101565443B New fir triterpene lactone compound, preparation method and application thereof
02/2011
02/16/2011EP2284176A1 Process for preparing guggulsterones and guggulsterol
02/09/2011CN101967171A Hydroxy removing process for eplerenone intermediate
02/03/2011US20110028711 Unsaturated Steroid Compounds
01/2011
01/27/2011US20110021472 17-hydroxy-19-nor-21-carboxylic acid-steroid y-lactone derivative, use thereof, and medicament containing the derivative
01/06/2011US20110003779 15, 16-methylene-17-(1'-propenyl)-17,3'-oxidoestra-4-en-3-one derivative , use thereof, and medicament containing said derivative
12/2010
12/16/2010US20100317632 17-(1'propenyl)-17-3'-oxidoestra-4-en-3-one derivative, use thereof, and medicament containing said derivative
12/15/2010CN101918426A 17-(1'-propenyl)-17-3'-oxidoestra-4-en-3-one derivative, use thereof, and medicament containing said derivative
12/09/2010US20100311702 19-nor-steroid derivatives with a 15alpha, 16alpha-methylene group and a saturated 17, 17-spiro-lactone ring, use thereof, and medicaments containing said derivatives
12/07/2010US7846917 18-Methyl-19-norandrost-4-ene 17, 17-spiro ether (18-methyl-19-nor-20-spirox-4-en-3-one), and pharmaceutical products comprising the same
11/2010
11/30/2010US7842680 Diene and triene compounds and formulations
11/25/2010US20100298281 Steroid-Derived Cyclopamine Analogs and Methods for Using the Same in the Prevention or Treatment of Cancer
10/2010
10/27/2010CN101318986B Method for synthesizing eplerenone
10/21/2010WO2010118560A1 Preparation method for eplerenone
10/20/2010CN101863951A Method for preparing eplerenone
10/14/2010WO2010118025A1 Progesterone antagonists spiro condensed in position 17 with a difluoromethylene- substituted perhydrofurane group
10/14/2010WO2010118023A1 Methods for the preparation of drospirenone
10/13/2010EP2238147A2 17-(1'-propenyl)-17-3'-oxidoestra-4-en-3-one derivative, use thereof, and medicament containing said derivative
09/2010
09/28/2010US7803936 Compounds and methods for labeling oligonucleotides
09/16/2010US20100234335 Neurosteroid compounds
09/02/2010US20100222571 Process for the preparation of drospirenone
08/2010
08/25/2010CN101812108A Synthesis of hydrocortisone butyrate
07/2010
07/27/2010US7763596 Antiinflamamtory agents; immunosuppressants; antiproliferative agents; treating haematology; reduced harmful side-effects
07/27/2010CA2427569C Selective glucocorticoid receptor agonists
07/22/2010US20100184735 Locally active "soft" antiandrogens
07/21/2010CN101784558A neurosteroid compounds
07/20/2010US7759330 21-substituted progesterone derivatives as new antiprogestational agents
06/2010
06/03/2010US20100137264 Progestational 3-(6,6-ethylene-17b-hydroxy-3-oxo-17a-pregna-4-ene-17a-yl)propionic acid g-lactones
06/02/2010CN101717426A Method for producing oxygen bridge material
06/01/2010US7728157 Oxidizing only a primary hydroxy on a fused ring to form an aldehyde, leaving the secondary OH alone; sulfating with pyridine:SO3 the primary OH on a fused ring leaving the secondary OH alone.
05/2010
05/06/2010US20100113408 21-substituted progesterone derivatives as new antiprogestational agents
04/2010
04/14/2010EP2173761A2 PROCESS FOR THE SYNTHESIS OF 9a-HYDROXY-STEROIDS
03/2010
03/31/2010CN101687903A Process for the synthesis of 9alpha-hydroxy-steroids
03/16/2010US7678781 11-phosphorous steroid derivatives useful as progesterone receptor modulators
03/10/2010EP2160398A2 INDUSTRIAL METHOD FOR THE SYNTHESIS OF 17-ACETOXY-11ß-[4-(DIMETHYLAMINO)-PHENYL]-21-METHOXY-19-NORPREGNA-4,9-DIEN-3,20-DIONE AND THE KEY INTERMEDIATES OF THE PROCESS
03/04/2010US20100056487 Modulators of amyloid-beta production
03/03/2010EP2158209A2 Neurosteroid compounds
02/2010
02/25/2010US20100048887 Compounds including an anti-inflammatory pharmacore and methods of use
02/23/2010US7667056 Process and new intermediates for the preparation of steroids with a progestogen activity
02/10/2010EP2150256A1 Locally active "soft" antiandrogens
01/2010
01/28/2010US20100022643 Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers
01/26/2010CA2427632C Process for the production of 4-(17.alpha.-substituted-3-oxoestra-4,9-dien-11.beta.-yl)benzaldehyde-(1e or 1z)-oximes
01/14/2010WO2009004394A8 PROCESS FOR THE SYNTHESIS OF 9α-HYDROXY-STEROIDS
01/12/2010US7645872 Compounds and methods for labeling oligonucleotides
01/07/2010WO2010000070A1 Methods for obtaining cyclopamine
01/07/2010CA2727986A1 Methods for obtaining cyclopamine
01/06/2010CN101622268A Industrial method for the synthesis of 17-acetoxy-11beta-[4-(dimethylamino)-phenyl]-21-methoxy-19-norpregna-4,9-dien-3,20-dione and the key intermediates of the process
01/06/2010CN100577681C Compounds, compositions and methods for treatment of inflammatory diseases and conditions
01/04/2010CA2636807A1 Methods for obtaining cyclopamine
12/2009
12/29/2009US7638509 Diene compounds and formulations
12/23/2009EP2135611A1 Pregn-5-en-20-yne-3,7,17-triol derivatives for use in therapy
12/10/2009CA2724130A1 Methods for preparing 17-alkynyl-7-hydroxy steroids and related compounds
12/09/2009CN101597316A Method for preparing drospirenone intermediates
12/09/2009CN100567320C Midbody of steroid, and application
12/03/2009WO2008155534A9 Neurosteroid compounds
11/2009
11/17/2009CA2406847C Regioselective and stereoselective oxidation of fused ring systems useful for the preparation of aminosterols
11/17/2009CA2402524C Methods of making and using 7.alpha.,11.beta.-dimethyl-17.beta.-hydroxy-4-estren-3-one 17.beta.-trans-4-n-butylcyclohexane carboxylate and 7.alpha.,11.beta.-dimethyl-17.beta.-hydroxyestr-4-en-3-one 17-undecanoate
11/12/2009CA2723689A1 Synthesis of (+) corstistatin a and related compounds
10/2009
10/28/2009CN101565443A New fir triterpene lactone compound, preparation method and application thereof
10/15/2009WO2009124460A1 Tripterygium wilfordii diterpene lactone derivatives, their pharmaceutical compositions and their application in inhibiting tumour of reproductive system
09/2009
09/24/2009WO2009083268A3 17-(1'-propenyl)-17-3'-oxidoestra-4-en-3-one derivative, use thereof, and medicament containing said derivative
09/08/2009CA2253673C 21-substituted progesterone derivatives as new antiprogestational agents
08/2009
08/27/2009US20090215890 Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers
08/19/2009CN100529759C Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents
08/11/2009US7572605 1,2,3,tris(4-hydroxy-butyroyloxy)propane; enhance the uptake of the drug, deliver effective therapeutic doses in a time-delayed fashion, and target specific organs
08/05/2009CN101497641A Method for synthesizing delta 24(28) cholesterol compounds
07/2009
07/29/2009EP2081951A1 Progesterone receptor antagonists
07/16/2009US20090181936 antiandrogen compounds, such as 3 beta -acetoxyandrost-1,5-diene-17-ethylene ketal and 3 beta -hydroxyandrost-1,5-diene-17-ethylene ketal, and methods for their use in the prevention and treatment of conditions mediated by androgen receptors, such as prostrate cancer
07/09/2009WO2009083268A2 17-(1'-propenyl)-17-3'-oxidoestra-4-en-3-one derivative, use thereof, and medicament containing said derivative
1 2 3 4 5 6 7 8 9 10 11 12 ... 16